<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://bloodjournal.hematologylibrary.org">
<title>Blood REVIEW IN TRANSLATIONAL HEMATOLOGY</title>
<link>http://bloodjournal.hematologylibrary.org</link>
<description>Blood RSS feed -- recent REVIEW IN TRANSLATIONAL HEMATOLOGY articles</description>
<prism:eIssn>1528-0020</prism:eIssn>
<prism:publicationName>Blood</prism:publicationName>
<prism:issn>0006-4971</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/4862?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://bloodjournal.hematologylibrary.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://bloodjournal.hematologylibrary.org/icons/banner/title.gif">
<title>Blood</title>
<url>http://bloodjournal.hematologylibrary.org/icons/banner/title.gif</url>
<link>http://bloodjournal.hematologylibrary.org</link>
</image>

<item rdf:about="http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/4862?rss=1">
<title><![CDATA[Beyond the increasing complexity of the immunomodulatory HLA-G molecule]]></title>
<link>http://bloodjournal.hematologylibrary.org/cgi/content/short/111/10/4862?rss=1</link>
<description><![CDATA[
<p>Human leukocyte antigen G (HLA-G) is a nonclassic major histocompatibility complex (MHC) class I molecule that functions as an immunomodulatory molecule capable of protecting fetal tissues from the maternal immune system. The relevance of HLA-G in other contexts was investigated soon afterward. Numerous studies have sought (and some have shown) the relevance of HLA-G in pathologic conditions, such as transplantation, autoimmunity, and cancer and hematologic malignancies. One of the main goals of the current research on HLA-G is now to use it in the clinic, either for diagnosis or as a therapeutic tool/target. For this, precise knowledge on the nature and functions of HLA-G is critical. We highlight here what we consider are recent key basic findings on the immunomodulatory function of HLA-G. These strengthen the case for considering HLA-G as clinically relevant.</p>
]]></description>
<dc:creator><![CDATA[Carosella, E. D., Favier, B., Rouas-Freiss, N., Moreau, P., LeMaoult, J.]]></dc:creator>
<dc:date>2008-05-08</dc:date>
<dc:subject><![CDATA[Immunobiology, Transplantation, Reviews in Translational Hematology]]></dc:subject>
<dc:identifier>info:doi/10.1182/blood-2007-12-127662</dc:identifier>
<dc:title><![CDATA[Beyond the increasing complexity of the immunomodulatory HLA-G molecule]]></dc:title>
<dc:publisher>American Society of Hematology</dc:publisher>
<prism:number>10</prism:number>
<prism:volume>111</prism:volume>
<prism:endingPage>4870</prism:endingPage>
<prism:publicationDate>2008-05-15</prism:publicationDate>
<prism:startingPage>4862</prism:startingPage>
<prism:section>REVIEW IN TRANSLATIONAL HEMATOLOGY</prism:section>
</item>

</rdf:RDF>